What does this research mean for the field?

Opioid recalls in the United States reflect significant manufacturing or quality assurance problems that undermine product reliability. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The research aims to analyze FDA drug recalls related to opioid medications and identify manufacturing issues.

February 25, 2026

Ver artículo completo

Characteristics of United States Food and Drug Administration Drug Recalls Involving Opioid Medications, 2002-2025.

Puntos clave

The research aims to analyze FDA drug recalls related to opioid medications and identify manufacturing issues.
Analysis of FDA recall data from 2002 to 2025
Assessment of manufacturing and quality assurance problems
Review of quantitative data for recalling practices
Identified trends in opioid medication recalls over the years
Highlighted specific quality assurance issues contributing to recalls
Emphasized the need for improved recall reporting in the pharmaceutical industry

Resumen

Opioid recalls reflect manufacturing or quality assurance problems that may undermine product reliability. More complete recall reporting, including quantitative data, would support efforts to reduce risks associated with pharmaceutical quality failures.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Nunes et al. (Sun,) studied this question.

synapsesocial.com/papers/699e91d7f5123be5ed04f970 https://doi.org/https://doi.org/10.1002/pds.70341

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo